Apyx Medical (APYX) Operating Expenses (2011 - 2026)

Apyx Medical (APYX) has reported Operating Expenses for 16 consecutive years, with $10.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 10.55% year-over-year to $10.7 million; the trailing twelve-month figure through Jun 2026 stood at $40.6 million (down 0.84% YoY), and the FY2025 full-year result was $39.5 million, down 18.08% from the prior year.
• Operating Expenses improved to $10.7 million in Q2 2026 per APYX's latest filing, from $8.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $14.7 million in Q4 2023 and bottomed at $8.7 million in Q1 2025.
• Historically, Operating Expenses has averaged $11.9 million across 5 years, with a median of $12.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 32.86% in 2022, then sank 30.63% in 2025.
• Over 5 years, Operating Expenses stood at $14.2 million in 2022, then grew by 3.68% to $14.7 million in 2023, then fell by 18.26% to $12.0 million in 2024, then decreased by 0.2% to $12.0 million in 2025, then retreated by 10.94% to $10.7 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $10.7 million, $8.8 million, and $12.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.